First-Mind: Primary Analysis from a Phase Ib, Open-Label, Randomized Study to Assess Safety of Tafasitamab or Tafasitamab + Lenalidomide in Addition to R-CHOP in Patients with Newl... von Belada, David, Kopeckova, Katerina, Bergua Burgues, Juan Miguel, Stevens, Don, André, Marc, Pérez Persona, Ernesto, Pichler, Petra, Staber, Philipp B., Trneny, Marek, Brackertz, Bettina, Shah, Neha, Sporchia, Andrea, Burke, John M., Nowakowski, Grzegorz S.

Volltext

First-MIND: A phase Ib, open-label, randomized study to assess safety of tafasitamab (tafa) or tafa + lenalidomide (LEN) in addition to R-CHOP in patients with newly diagnosed DLBC... von Belada, David, Kopeckova, Katerina, Bergua, Juan Miguel, André, Marc, Perez Persona, Ernesto, Pichler, Petra, Klöpfer, Pia, Brackertz, Bettina, Lohrmann, Emanuel, Lahiry, Anirban, Shah, Neha, Brugger, Wolfram, Burke, John M., Nowakowski, Grzegorz S.

Volltext

A Phase Ib, Open-Label, Randomized Study to Assess Safety and Preliminary Efficacy of Tafasitamab (MOR208) or Tafasitamab + Lenalidomide in Addition to R-CHOP in Patients with Newl... von Belada, David, Nowakowski, Grzegorz S., Bergua Burgues, Juan Miguel, André, Marc, Kopeckova, Katerina, Stevens, Don A., Trněný, Marek, Pérez Persona, Ernesto, Pichler, Petra, Klöpfer, Pia, Brackertz, Bettina, Lohrmann, Emanuel, Lahiry, Anirban, Shah, Neha, Fingerle-Rowson, Günter, Brugger, Wolfram, Burke, John M.

Volltext

PD-1 expression on Melan-A-reactive T cells increases during progression to metastatic disease von Krönig, Holger, Julia Falchner, Kathrin, Odendahl, Marcus, Brackertz, Bettina, Conrad, Heinke, Muck, Dieter, Hein, Rüdiger, Blank, Christian, Peschel, Christian, Haller, Bernhard, Schulz, Stephan, Bernhard, Helga

Volltext

Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6 von Witzens-Harig, Mathias, Hose, Dirk, Jünger, Simone, Pfirschke, Christina, Khandelwal, Nisit, Umansky, Ludmila, Seckinger, Anja, Conrad, Heinke, Brackertz, Bettina, Rème, Thierry, Gueckel, Brigitte, Meißner, Tobias, Hundemer, Michael, Ho, Anthony D., Rossi, Jean-Francois, Neben, Kai, Bernhard, Helga, Goldschmidt, Hartmut, Klein, Bernard, Beckhove, Philipp

Volltext

Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex von Stahl, Sonja, Gaetzner, Sabine, Voss, Katrin, Brackertz, Bettina, Schleider, Elisa, Sürücü, Oguzkan, Kunze, Ekkehard, Netzer, Christian, Korenke, Christoph, Finckh, Ulrich, Habek, Mario, Poljakovic, Zdravka, Elbracht, Miriam, Rudnik-Schöneborn, Sabine, Bertalanffy, Helmut, Sure, Ulrich, Felbor, Ute

Volltext

Human Multiple Myeloma and Breast Cancer Cells Evade Immune Rejection Through Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 von Witzens-Harig, Mathias, Hose, Dirk, Jünger, Simone, Pfirschke, Christina, Khandelwal, Nisit, Seckinger, Anja, Conrad, Heinke, Brackertz, Bettina, Reme, Thierry, Gückel, Brigittte, Meissner, Tobias, Hundemer, Michael, Ho, Anthony D, Rossi, Jean-Francois, Neben, Kai, Bernhard, Helga, Goldschmidt, Hartmut, Klein, Bernard, Beckhove, Philipp

Volltext

ANTI-BSEP-SPECIFIC ANTIBODIES von KLATTIG, Jürgen, TILLER, Thomas, BRACKERTZ, Bettina, HÄUSSINGER, Dieter, KEITEL-ANSELMINO, Verena, STINDT, Jan, KUBITZ, Ralf

Volltext bestellen

FLT3-regulierte, Leukämie-assoziierte Antigene als Zielstrukturen für zytotoxische T-Lymphozyten von Brackertz, Bettina

Volltext bestellen